Cephalon Takes Another Blow Over Provigil

Law360 (June 30, 2006, 12:00 AM EDT) -- As the battle over Cephalon Inc.’s narcolepsy drug Provigil continues to swell, generic drug maker Apotex has joined the fray, filing its own lawsuit accusing the pharmaceutical company and a slew of rival generic makers of barring competition by entering into a deal to delay introducing copycat versions of the drug.

The lawsuit, filed in the U.S. District Court for the Eastern District of Pennsylvania, is the latest in a string of charges against Cephalon in recent months over modafinil, the active ingredient in Provigil....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.